Axsome Therapeutics (AXSM) Up Nearly 500% in 2019

It’s one of the hottest biotech stocks of 2019. Since the year began, shares of Axsome Therapeutics Inc. (NASDAQ:AXSM), a clinical stage biopharmaceutical company that is developing novel therapies for central nervous system (CNS) disorders, has exploded from less than $3 to $17.68. It’s pushing higher in response to positive clinical data regarding one of … Continue reading “Axsome Therapeutics (AXSM) Up Nearly 500% in 2019”